Apple has patented a design for a device that would help monitor blood pressure more seamlessly.
Apple has patented a design for a device that would help monitor blood pressure more seamlessly.
The design is for a wearable blood pressure monitor, which would resemble a cuff, and come equipped with sensors that track the blood pressure of the wearer, The Verge has reported. The patent further describes the device to come equipped with a touchscreen and possible inclusion of bluetooth support.
Recently, Apple announced that researchers and developers will soon have access to a Health Records API, allowing them to further health research and give US consumers a more individual experience.
The Health Records feature already allows patients of more than 500 hospitals and clinics in the US to access their medical information from various institutions so it can be organized into one view on their iPhone.
With Apple's new move, for the first time consumers will be able to share their medical records with their favorite trusted apps, which, with their permission, will also become available to researchers and developers, helping users to improve their overall health.
Developers building health apps will be able to give a more personalized experience by accessing a user's unique health history across key categories such as Medisafe, a medication management app which will connect with the Health Records feature so users can easily import their prescription list from several hospitals and clinics, set pill reminders, and receive information from Medisafe about potential problems with drug interactions.
A diabetes app could also access a patient's lab results from their Health Records as well as their diet and exercise details for a fuller picture of health and how to manage the disease, while a healthy eating app could offer users tailored nutrition programs based on their high blood pressure or cholesterol results to help improve the conditions.
Allowing researchers access to the new Health Records API, again with participants' approval, will also ensure more comprehensive research without the need to rely on survey questionnaires and patients' self-reports, which can be prone to error.
With inputs from ANI
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
 "Apple")
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
)
){kind=small}
){kind=small}
)
)
)
)
)
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}